These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 4596808

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Long-term skin allograft survical elicited by a finite treatment with antilymphocyte serum combined with cytarabine.
    Perper RJ, Monovich RE, Bowersox BE.
    J Immunol; 1970 May; 104(5):1063-71. PubMed ID: 4910473
    [No Abstract] [Full Text] [Related]

  • 23. An in vivo antilymphocytic serum (ALS) efficacy test.
    van den Broek AA, Wildevuur CR.
    Br J Surg; 1972 Apr; 59(4):311. PubMed ID: 4553600
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Tolerance induction with anti-CD8 monoclonal antibodies in the mouse heart transplant model.
    Mottram PL, Purcell LJ, Pietersz GA, McKenzie IF.
    Transplant Proc; 1993 Oct; 25(5):2935-6. PubMed ID: 8212289
    [No Abstract] [Full Text] [Related]

  • 29. Trypanosome-mediated suppression of murine humoral immunity independent of typical suppressor cells.
    Albright JW, Albright JF.
    J Immunol; 1980 May; 124(5):2481-4. PubMed ID: 6444974
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA, Wood ML, Monaco AP.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
    Thierfelder S, Hoffmann-Fezer G, Rodt H, Doxiadis I, Eulitz M, Kummer U.
    Transplantation; 1983 Mar; 35(3):249-54. PubMed ID: 6340277
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Mediation of an endotoxic effect by macrophages.
    Moore RN, Goodrum KJ, Berry LJ.
    J Reticuloendothel Soc; 1976 Mar; 19(3):187-97. PubMed ID: 1083433
    [No Abstract] [Full Text] [Related]

  • 37. Cardiac and skin heterograft rejection: suppression with antilymphocyte serum.
    Donawick WJ, Shaffer CF, Dodd DC, Buchanan JW, Fregin GF.
    Transplant Proc; 1971 Mar; 3(1):551-3. PubMed ID: 4937937
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Skin grafts in nude mice. 2. Rat skin grafts in nude mice of three genetic backgrounds (BALB-c, C3H, C57-BL). The effects after preparation by thymus grafts.
    Rygaard J.
    Acta Pathol Microbiol Scand A; 1974 Jan; 82(1):93-104. PubMed ID: 4597212
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.